SCHEMBL7418946

SCHEMBL7418946

CCCC(=O)C(C(=O)O)N(C)Cc1ccsc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 2/20 0.40
▸ MME P08473 3/20 0.39
▸ SLC1A3 P43003 2/20 0.38
▸ SLC1A2 P43004 2/20 0.38
▸ SLC1A1 P43005 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ TRPM8 Q7Z2W7 1/20 0.38
▸ HCAR3 P49019 2/20 0.37
▸ HCAR2 Q8TDS4 1/20 0.37
▸ DRD2 P14416 1/20 0.37
▸ DRD3 P35462 1/20 0.37
▸ OPRM1 P35372 2/20 0.36
▸ OPRD1 P41143 2/20 0.36
▸ OPRK1 P41145 2/20 0.36
▸ PTGS1 P23219 1/20 0.36
▸ PTGS2 P35354 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ CHRM2 P08172 2/20 0.36
▸ CHRM1 P11229 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7426280 0.76 POLB (0.47) HSD11B1TRPM8KMT2A
SCHEMBL7418944 0.73 TRPM8 (0.45) HSD11B1SLC1A3SLC1A2SLC1A1RAB9A
SCHEMBL13600521 0.69 DRD2 (0.42) HSD11B1RAB9ATRPM8HCAR3HCAR2
SCHEMBL12313813 0.67 HSD11B1 (0.58) HSD11B1RAB9ATRPM8HCAR3HCAR2
SCHEMBL21400129 0.66 HSD11B1 (0.56) HSD11B1RAB9ATRPM8HCAR3HCAR2
SCHEMBL11179311 0.66 NPC1 (0.53) RAB9AOPRK1NPC1KMT2A
SCHEMBL6667849 0.65 HSD11B1 (0.51) HSD11B1RAB9ATRPM8HCAR3HCAR2
SCHEMBL7501656 0.65 — —
SCHEMBL7418074 0.65 MME (0.56) MMESLC1A3SLC1A2SLC1A1OPRM1
SCHEMBL4314631 0.65 SLC1A3 (0.53) MMESLC1A3SLC1A2SLC1A1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1265903-A1 THIEPINO[3,2-B]DIHYDROPYRIDINES AND RELATED COMPOSITIONS AND METHODS Ortho-Mcneil Pharmaceutical, Inc. (US) 2002-12-18 — — EP disclosed
US-6420383-B1 CALCIUM CHANNEL BLOCKERS, HYPERSENSITIVITY, ALLERGY, ASTHMA, BRONCHOSPASM, DYSMENORRHEA, ESOPHAGEAL SPASM, GLAUCOMA, PREMATURE LABOR, URINARY TRACT DISORDERS, GASTROINTESTINAL MOTILITY DISORDERS AND CARDIOVASCULAR DISORDERS. ORTHO-MCNEIL PHARMACEUTICAL, INC. 2002-07-16 — — US disclosed
WO-2001070748-A1 THIEPINO [3,2-b] DIHYDROPYRIDINES AND RELATED COMPOSITIONS AND METHODS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2001-09-27 — — WO disclosed
Send feedback